Indication: Hematopoietic Stem Cell Donors
Identifying Predictors of Poor Health-Related Quality-of-Life among Pediatric Hematopoietic Stem Cell Donors
Sub-indication: Hematopoietic Stem Cell Donors
Study Type: Observational
Principal Investigator: William Tse, M.D.Norton Children's Cancer Institute, affiliated with the UofL School of Medicine
Sponsor: Sponsor: Pediatric Blood and Marrow Transplant Consortium (
Learn more at ClinicalTrials.gov
Email for more information: NCRI-Cancer@NortonHealthcare.org
